Total and free deoxypyridinoline after acute osteoclast activity inhibition

Clin Chem. 1999 Sep;45(9):1510-6.

Abstract

Background: Deoxypyridinoline (Dpd) is one of the two pyridinium cross-links that provide structural rigidity to type I collagen in bone. During osteoclastic resorption, Dpd is released into circulation and is excreted in the urine in free and peptide-bound forms. Free and total Dpd are highly correlated, but whether the free-to-total cross-link ratio is constant in both normal and high bone turnover states remains controversial. To compare free and total Dpd performance in a physiological condition, urinary free and total Dpd were measured after a short-term inhibition of osteoclast activity such as that induced by an oral calcium load.

Methods: Total and free Dpd were measured by HPLC and by immunosorbent assay, respectively, in two groups of subjects, one (calcium-treated; n = 16) taking calcium and the other not (control; n = 9).

Results: The urinary excretion of total Dpd at 2 and 4 h after oral calcium loading was decreased compared with controls. By contrast, changes in free Dpd were similar in the calcium-treated and control groups, reflecting only circadian rhythm.

Conclusions: Total and free Dpd do not show comparable sensitivity in detecting short-term inhibition of osteoclast activity. The degradation process of peptide-bound to free Dpd could render free Dpd insensitive to acute changes of osteoclast activity.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acids / metabolism
  • Amino Acids / urine*
  • Biomarkers / urine
  • Bone Resorption / urine
  • Calcium
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Immunoassay
  • Male
  • Middle Aged
  • Osteoclasts / metabolism*
  • Peptides / metabolism
  • Protein Binding
  • Sensitivity and Specificity

Substances

  • Amino Acids
  • Biomarkers
  • Peptides
  • deoxypyridinoline
  • Calcium